Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

Rhea-AI Summary

Kewaunee Scientific (NASDAQ: KEQU) said it will release third quarter fiscal 2026 results on Wednesday, March 11, 2026 after market close. Results will be posted on the company website.

The announcement reiterates corporate profile, global manufacturing footprint and the recently acquired subsidiary Nu Aire.

News Market Reaction – KEQU

-2.08%

-2.08% Session close to close

In the Feb 26 session, KEQU declined 2.08%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the date for Kewaunee’s Q3 FY26 results and reiterates its expanded platform,...

Analysis

This announcement sets the date for Kewaunee’s Q3 FY26 results and reiterates its expanded platform, including Nu Aire and global manufacturing sites. With no financial figures or guidance included, the key context comes from prior filings and earnings, which highlighted growth and acquisition integration. Investors may focus on how upcoming results reflect backlog conversion, margin trends, and the contribution from Nu Aire to overall performance.

Key Figures

Earnings release date: March 11, 2026 Company founding: 1906 Statesville plants: 3 manufacturing facilities +3 more

6 metrics

Earnings release date March 11, 2026 Planned Q3 FY26 results release after close of trading

Company founding 1906 Year Kewaunee Scientific was founded

Statesville plants 3 manufacturing facilities Facilities in Statesville serving domestic and international markets

Bangalore plant 1 manufacturing facility Facility in Bangalore serving local, Asian, and African markets

Nu Aire founding 1971 Year Nu Aire, the newly acquired subsidiary, was founded

Investor contact phone 704-871-3274 Phone number for company contact listed in the release

Previous Earnings date Reports

1 past event · Latest: Nov 26 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 26	Earnings date notice	Neutral	-3.0%	Announced timing of Q2 FY26 results release after market close.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date notice on Nov 26, 2025 saw a modest -2.96% move, suggesting scheduling updates have previously coincided with slight downside.

Recent Company History

Recent history shows Kewaunee combining operational growth with balance sheet actions. The last earnings-date notice on Nov 26, 2025 simply flagged the upcoming Q2 release and coincided with a -2.96% move. This new announcement similarly sets the timetable for Q3 FY26 results and reiterates the company’s expanded footprint, including the Nu Aire acquisition and multi-country manufacturing network.

Key Terms

forward-looking statements, form 10-k, form 10-q, form 8-k, +1 more

5 terms

forward-looking statements regulatory

"This press release contains statements that the Company believes to be "forward-looking statements""

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2025"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

form 10-q regulatory

"and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

form 8-k regulatory

"and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

biological safety cabinets medical

"Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators"

An enclosed, ventilated workspace that keeps lab workers, the surrounding environment, and delicate biological samples separate by controlling airflow and filtering out contaminants—think of it as a clean, protective box that prevents germs and particles from spreading. Investors care because these cabinets are required for safe research, clinical testing and manufacturing; their presence affects a lab’s ability to operate legally and reliably, influencing regulatory risk, operating costs and the pace at which scientific work can be commercialized.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STATESVILLE, N.C., Feb. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results on Wednesday, March 11, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/. 

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2025, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:	Donald T. Gardner III
	704/871-3274

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-report-results-for-third-quarter-fiscal-year-2026-302697094.html

SOURCE Kewaunee Scientific Corporation

FAQ

When will Kewaunee Scientific (KEQU) report third quarter fiscal 2026 results?

Kewaunee Scientific will release Q3 fiscal 2026 results on March 11, 2026 after market close. According to the company, financial results and related materials will be available on the company's website following the release for investor review and download.

Where can investors find Kewaunee Scientific (KEQU) Q3 2026 financial results and documents?

Investors can access Q3 2026 results on the company's investor website at www.kewaunee.com. According to the company, the release and any supplemental materials will be posted on the website after the March 11, 2026 after-market announcement.

Does Kewaunee Scientific (KEQU) mention any recent acquisitions relevant to the March 2026 report?

Yes, the company references its newly acquired subsidiary Nu Aire, which complements its lab product portfolio. According to the company, Nu Aire adds biological safety cabinets, CO2 incubators and ultralow freezers to Kewaunee's offerings and manufacturing footprint.

What global operations does Kewaunee Scientific (KEQU) describe ahead of the Q3 2026 release?

Kewaunee Scientific notes manufacturing in Statesville, NC and Bangalore, India, plus sales offices in the United States, India, Saudi Arabia and Singapore. According to the company, these facilities serve domestic, Asian and African markets.

Will Kewaunee Scientific (KEQU) provide forward-looking statements with the Q3 2026 release?

Yes, the company warns the release may include forward-looking statements about future results and risks. According to the company, statements use words like "expect" and "plan" and are subject to risks described in its 2025 Form 10-K and subsequent filings.